Overview

Lactobacillus Reuteri in Management of Helicobacter Pylori Infection in Dyspeptic Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Addition of L. reuteri to the standard triple therapy improves H. Pylori treatment outcomes.
Phase:
N/A
Details
Lead Sponsor:
Zagazig University
Collaborator:
BioGaia AB
Treatments:
Amoxicillin
Clarithromycin
Omeprazole